122 related articles for article (PubMed ID: 23669249)
1. Effect of atorvastatin and methotrexate on solid Ehrlich tumor.
Kabel AM; Abdel-Rahman MN; El-Sisi Ael-D; Haleem MS; Ezzat NM; El Rashidy MA
Eur J Pharmacol; 2013 Aug; 713(1-3):47-53. PubMed ID: 23669249
[TBL] [Abstract][Full Text] [Related]
2. Comparative study between the effect of methotrexate and valproic acid on solid Ehrlich tumour.
Abdel-Rahman MN; Kabel AM
J Egypt Natl Canc Inst; 2012 Dec; 24(4):161-7. PubMed ID: 23159286
[TBL] [Abstract][Full Text] [Related]
3. Effect of metformin and adriamycin on transplantable tumor model.
Kabel AM; Omar MS; Balaha MF; Borg HM
Tissue Cell; 2015 Oct; 47(5):498-505. PubMed ID: 26276089
[TBL] [Abstract][Full Text] [Related]
4. Apigenin potentiates the antitumor activity of 5-FU on solid Ehrlich carcinoma: Crosstalk between apoptotic and JNK-mediated autophagic cell death platforms.
Gaballah HH; Gaber RA; Mohamed DA
Toxicol Appl Pharmacol; 2017 Feb; 316():27-35. PubMed ID: 28025107
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effect of atorvastatin ameliorates insulin resistance in monosodium glutamate-treated obese mice.
Furuya DT; Poletto AC; Favaro RR; Martins JO; Zorn TM; Machado UF
Metabolism; 2010 Mar; 59(3):395-9. PubMed ID: 19800637
[TBL] [Abstract][Full Text] [Related]
6. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
[TBL] [Abstract][Full Text] [Related]
7. Effect of hesperidin on mice bearing Ehrlich solid carcinoma maintained on doxorubicin.
Khedr NF; Khalil RM
Tumour Biol; 2015 Dec; 36(12):9267-75. PubMed ID: 26099723
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin and celecoxib inhibit prostate PC-3 tumors in immunodeficient mice.
Zheng X; Cui XX; Avila GE; Huang MT; Liu Y; Patel J; Kong AN; Paulino R; Shih WJ; Lin Y; Rabson AB; Reddy BS; Conney AH
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5480-7. PubMed ID: 17875778
[TBL] [Abstract][Full Text] [Related]
9. Antiarrhythmic effect of atorvastatin on autoimmune myocarditis is mediated by improving myocardial repolarization.
Tang Q; Huang J; Qian H; Chen L; Wang T; Wang H; Shen D; Wu H; Xiong R
Life Sci; 2007 Jan; 80(7):601-8. PubMed ID: 17217967
[TBL] [Abstract][Full Text] [Related]
10. Anti-cancer and cardioprotective effects of indol-3-carbinol in doxorubicin-treated mice.
Adwas AA; Elkhoely AA; Kabel AM; Abdel-Rahman MN; Eissa AA
J Infect Chemother; 2016 Jan; 22(1):36-43. PubMed ID: 26603425
[TBL] [Abstract][Full Text] [Related]
11. Trehalose enhances the antitumor potential of methotrexate against mice bearing Ehrlich ascites carcinoma.
El-Magd MA; Khamis A; Nasr Eldeen SK; Ibrahim WM; Salama AF
Biomed Pharmacother; 2017 Aug; 92():870-878. PubMed ID: 28599251
[TBL] [Abstract][Full Text] [Related]
12. Effect of low doses of atorvastatin on adiponectin, glucose homeostasis, and clinical inflammatory markers in kidney transplant recipients.
Bayés B; Granada ML; Lauzurica R; Pastor MC; Navarro M; Bonet J; Llopis MA; Romero R
Transplant Proc; 2005 Nov; 37(9):3808-12. PubMed ID: 16386546
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of methotrexate-loaded poly(ε-caprolactone) implants in Ehrlich solid tumor-bearing mice.
Pereira Ade F; Pereira LG; Barbosa LA; Fialho SL; Pereira BG; Patricio PS; Pinto FC; Da Silva GR
Drug Deliv; 2013; 20(3-4):168-79. PubMed ID: 23738591
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
Nachtigal P; Pospisilova N; Jamborova G; Pospechova K; Solichova D; Andrys C; Zdansky P; Micuda S; Semecky V
Life Sci; 2008 Mar; 82(13-14):708-17. PubMed ID: 18289605
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effect of atorvastatin involves suppression of TNF-α and upregulation of IL-10 in a rat model of intracerebral hemorrhage.
Ewen T; Qiuting L; Chaogang T; Tao T; Jun W; Liming T; Guanghong X
Cell Biochem Biophys; 2013 Jun; 66(2):337-46. PubMed ID: 23090788
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.
Harikrishnan S; Rajeev E; Tharakan JA; Titus T; Ajit Kumar VK; Sivasankaran S; Krishnamoorthy KM; Nair K
Indian Heart J; 2008; 60(3):215-22. PubMed ID: 19240310
[TBL] [Abstract][Full Text] [Related]
17. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
[TBL] [Abstract][Full Text] [Related]
18. Lack of efficacy of the statins atorvastatin and lovastatin in rodent mammary carcinogenesis.
Lubet RA; Boring D; Steele VE; Ruppert JM; Juliana MM; Grubbs CJ
Cancer Prev Res (Phila); 2009 Feb; 2(2):161-7. PubMed ID: 19196723
[TBL] [Abstract][Full Text] [Related]
19. Antitumor and apoptosis promoting properties of atorvastatin, an inhibitor of HMG-CoA reductase, against Dalton's Lymphoma Ascites tumor in mice.
Ajith TA; Anu V; Riji T
J Exp Ther Oncol; 2008; 7(4):291-8. PubMed ID: 19227009
[TBL] [Abstract][Full Text] [Related]
20. Promising role of ferulic acid, atorvastatin and their combination in ameliorating high fat diet-induced stress in mice.
Kesh SB; Sikder K; Manna K; Das DK; Khan A; Das N; Dey S
Life Sci; 2013 May; 92(17-19):938-49. PubMed ID: 23567805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
